Close
Smartlab Europe
Achema middle east

Yuvraj

Pfizer establishes gene therapy unit for rare disease research

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast...

EFPIA hails joint action on counterfeit drugs

The pan-European medicines verification system uses an anti-tampering device together with 2D barcoding to verify the authenticity of medicinal products and is currently being...

TxCell announces start of phase IIb clinical trial with Ovasave(R) for refractory Crohn’s disease

TxCell undertaking one of largest ever controlled studies for a personalized T cell immunotherapy product . Top line results of this study are...

Washington University-developed new breast cancer vaccine shows promise

Researchers at Washington University School of Medicine in St. Louis, US, have reported preliminary data from a small clinical trial of a new breast...

Evotec and Sanofi negotiate drug discovery collaboration and pre-clinical development

Germany-based Evotec is negotiating with French drugmaker Sanofi for a multi-component strategic collaboration over the next five years. The ...

Japan’s Otsuka to acquire Avanir for $3.5bn

Japan-based Otsuka Pharmaceutical has signed an agreement to acquire US-based Avanir Pharmaceuticals for $3.5bn. Otsuka, through its wholly-owned subsidiary Otsuka...

Mylan and Gilead partner for TAF-based HIV treatments in developing markets

Mylan Laboratories has signed an agreement with Gilead Sciences to increase access to Tenofovir Alafenamide (TAF) based HIV treatments in developing countries....

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »